Long-term effects of cardiac rehabilitation after heart valve surgery - results from the randomised CopenHeartVR trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 1,91 MB, PDF-dokument

Aims. The CopenHeartVR trial found positive effects of cardiac rehabilitation (CR) on physical capacity at 4 months. The long-term effects of CR following valve surgery remains unclear, especially regarding readmission and mortality. Using data from he CopenHeartVR Trial we investigated long-term effects on physical capacity, mental and physical health and effect on mortality and readmission rates as prespecified in the original protocol. Methods. A total of 147 participants were included after heart valve surgery and randomly allocated 1:1 to 12-weeks exercise-based CR including a psycho-educational programme (intervention group) or control. Physical capacity was assessed as peak oxygen uptake (VO2 peak) measured by cardiopulmonary exercise testing, mental and physical health by Short Form-36 questionnaire, Hospital Anxiety and Depression Scale, and HeartQol. Mortality and readmission were obtained from hospital records and registers. Groups were compared using mixed regression model analysis and log rank test. Results. No differences in VO2 peak at 12 months or in self-assessed mental and physical health at 24 months (68% vs 75%, p =.120) was found. However, our data demonstrated reduction in readmissions in the intervention group at intermediate time points; after 3, 6 (43% vs 59%, p =.03), and 12 (53% vs 67%, p =.04) months, respectively, but no significant effect at 24 months. Conclusions. Exercise-based CR after heart valve surgery reduces combined readmissions and mortality up to 12 months despite lack of improvement in exercise capacity, physical and mental health long-term. Exercise-based CR can ensure short-term benefits in terms of physical capacity, and lower readmission within a year, but more research is needed to sustain these effects over a longer time period. These considerations should be included in the management of patients after heart valve surgery.

OriginalsprogEngelsk
TidsskriftScandinavian Cardiovascular Journal
Vol/bind56
Udgave nummer1
Sider (fra-til)247-255
Antal sider9
ISSN1401-7431
DOI
StatusUdgivet - 2022

Bibliografisk note

Funding Information:
The Danish Strategic Research Foundation [10-092790]; The Heart Centre Research Council, Rigshospitalet; Familien Hede Nielsen Foundation [2013-1226]; The National Institute of Public Health, University of Southern Denmark; and Region Zealand Health Research Foundation, Denmark [12-000095/jun2014]. The funders had no influence on the trial design, execution of the trial or interpretation of data. All 147 participants are acknowledged.

Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.

ID: 329284952